The June Hot Topics focuses on the challenges venetoclax regimens have faced in multiple myeloma trials.
Zachary M. Avigan, MD
Advertisement
Articles by Zachary M. Avigan, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Vepdegestrant in ER+, HER2–, ESR1-Mutated Breast Cancer
2
FDA ODAC Votes Yes to Capivasertib for PTEN-Deficient Metastatic HSPC
3
FDA Permits Expanded Daraxonrasib Access in Previously Treated Metastatic PDAC
4
FDA ODAC Votes No to Camizestrant for HR+/HER2– ESR1 Advanced Breast Cancer
5